Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression

Details 詳細情報について

• CRID

  1361137044131371264

• DOI

  10.1530/erc-14-0268

• ISSN

  14796821

  13510088

• Web Site

  https://erc.bioscientifica.com/downloadpdf/journals/erc/21/5/755.xml

• Data Source

  • Crossref